Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2016, Article ID 8290963, 17 pages
http://dx.doi.org/10.1155/2016/8290963
Review Article

Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems

Dry Powder Inhaler Lab, Respiratory Formulations, Cipla R & D, LBS Road, Vikhroli (W), Mumbai, Maharashtra 400079, India

Received 11 August 2016; Revised 25 September 2016; Accepted 9 October 2016

Academic Editor: Ali Nokhodchi

Copyright © 2016 Piyush Mehta. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Winkler, G. Hochhaus, and H. Derendorf, “How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids,” Proceedings of the American Thoracic Society, vol. 1, pp. 356–363, 2004. View at Publisher · View at Google Scholar
  2. M. K. Al-Hallak, M. K. Sarfraz, S. Azarmi, W. H. Roa, W. H. Finlay, and R. Löbenberg, “Pulmonary delivery of inhalable nanoparticles: dry powder inhalers,” Therapeutic Delivery, vol. 2, no. 10, pp. 1313–1324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Healy, M. I. Amaro, K. J. Paluch, and L. Tajber, “Dry powders for oral inhalation free of lactose carrier particles,” Advanced Drug Delivery Reviews, vol. 75, pp. 32–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Hoppentocht, P. Hagedoorn, H. W. Frijlink, and A. H. de Boer, “Technological and practical challenges of dry powder inhalers and formulations,” Advanced Drug Delivery Reviews, vol. 75, pp. 18–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Liu and G. Huang, “Formation strategies, mechanism of intracellular delivery and potential clinical applications of pH-sensitive liposomes,” Asian Journal of Pharmaceutical Sciences, vol. 8, no. 6, pp. 319–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Akbarzadeh, R. Rezaei-Sadabady, S. Davaran et al., “Liposome: classification, preparation, and applications,” Nanoscale Research Letters, vol. 8, article 102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Clancy, L. Dupont, M. W. Konstan et al., “Phase II studies of nebulised arikace in CF patients with Pseudomonas aeruginosa infection,” Thorax, vol. 68, no. 9, pp. 818–825, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Sinha, S. Mukhopadhyay, N. Das, and M. Basu, “Targeting of liposomal andrographolide to L. donovani infected macrophages in vivo,” Drug Delivery, vol. 7, no. 4, pp. 209–213, 2000. View at Google Scholar
  9. S. P. Shah and A. Misra, “Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance,” AAPS PharmSciTech, vol. 5, no. 4, pp. 1–7, 2004. View at Google Scholar · View at Scopus
  10. M. R. Joshi and A. Misra, “Liposomal budesonide for dry powder inhaler: preparation and stabilization,” AAPS PharmSciTech, vol. 2, no. 4, pp. 1–10, 2001. View at Google Scholar · View at Scopus
  11. M. Chougule, B. Padhi, and A. Misra, “Development of spray dried liposomal dry powder inhaler of dapsone,” AAPS PharmSciTech, vol. 9, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Gandhi, T. Pandya, R. Gandhi et al., “Inhalable liposomal dry powder of gemcitabine-HCl: formulation, in vitro characterization and in vivo studies,” International Journal of Pharmaceutics, vol. 496, no. 2, pp. 886–895, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Joshi and A. Misra, “Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization,” International Journal of Pharmaceutics, vol. 223, no. 1-2, pp. 15–27, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. F. Ourique, P. D. S. Chaves, G. D. Souto, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, “Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: development, in vitro characterization and antioxidant activity,” European Journal of Pharmaceutical Sciences, vol. 65, pp. 174–182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gibbons, N. G. McElvaney, and S.-A. Cryan, “A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation,” AAPS PharmSciTech, vol. 11, no. 3, pp. 1411–1421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. L. Manca, D. Valenti, O. D. Sales, A. Nacher, A. M. Fadda, and M. Manconi, “Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin,” International Journal of Pharmaceutics, vol. 472, no. 1-2, pp. 102–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-H. Huang, Z.-J. Yang, H. Wu, Y.-F. Wong, Z.-Z. Zhao, and L. Liu, “Development of liposomal salbutamol sulfate dry powder inhaler formulation,” Biological and Pharmaceutical Bulletin, vol. 33, no. 3, pp. 512–517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. B. Chougule, B. K. Padhi, and A. Misra, “Nano-liposomal dry powder inhaler of amiloride hydrochloride,” Journal of Nanoscience and Nanotechnology, vol. 6, no. 9-10, pp. 3001–3009, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Chougule, B. Padhi, and A. Misra, “Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics,” International Journal of Nanomedicine, vol. 2, no. 4, pp. 675–688, 2007. View at Google Scholar · View at Scopus
  20. W. Rojanarat, N. Changsan, E. Tawithong, S. Pinsuwan, H.-K. Chan, and T. Srichana, “Isoniazid pro-liposome powders for inhalation-preparation, characterization and cell culture studies,” International Journal of Molecular Sciences, vol. 12, no. 7, pp. 4414–4434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Patil-Gadhe and V. Pokharkar, “Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach,” Pulmonary Pharmacology & Therapeutics, vol. 27, no. 2, pp. 197–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. O. B. Garbuzenko, G. Mainelis, O. Taratula, and T. Minko, “Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention,” Cancer Biology and Medicine, vol. 11, no. 1, pp. 44–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. K. M. G. Taylor and J. M. Newton, “Liposomes for controlled delivery of drugs to the lung,” Thorax, vol. 47, no. 4, pp. 257–259, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Shah, O. Taratula, O. B. Garbuzenko et al., “Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids,” Current Drug Discovery Technologies, vol. 10, no. 1, pp. 8–15, 2013. View at Google Scholar · View at Scopus
  25. A. A. Abdelbary, A. M. Al-Mahallawi, M. E. Abdelrahim, and A. M. A. Ali, “Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration,” International Journal of Nanomedicine, vol. 10, pp. 6339–6353, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Kumar, S. Soni, A. Jaimini, F. J. Ahmad, A. Bhatnagar, and G. Mittal, “Edetate calcium disodium nanoparticle dry powder inhalation: a novel approach against heavy metal decorporation,” International Journal of Pharmaceutics, vol. 416, no. 1, pp. 376–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Sinsuebpol, J. Chatchawalsaisin, and P. Kulvanich, “Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery,” Drug Design, Development and Therapy, vol. 7, pp. 861–873, 2013. View at Google Scholar · View at Scopus
  28. N. El-Gendy, E. M. Gorman, E. J. Munson, and C. Berkland, “Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution,” Journal of Pharmaceutical Sciences, vol. 98, no. 8, pp. 2731–2746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Kho and K. Hadinoto, “Optimizing aerosolization efficiency of dry-powder aggregates of thermally-sensitive polymeric nanoparticles produced by spray-freeze-drying,” Powder Technology, vol. 214, no. 1, pp. 169–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. El-Gendy, W. Pornputtapitak, and C. Berkland, “Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols,” European Journal of Pharmaceutical Sciences, vol. 44, no. 4, pp. 522–533, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Salem, M. Abdelrahim, K. A. Eid, and M. Sharaf, “Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler,” International Journal of Nanomedicine, vol. 6, pp. 311–320, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Li, F. G. Vogt, D. Hayes Jr., and H. M. Mansour, “Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery,” European Journal of Pharmaceutical Sciences, vol. 52, no. 1, pp. 191–205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Meenach, K. Anderson, J. Hilt, R. McGarry, and H. Mansour, “High performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies,” AAPS PharmSciTech, vol. 15, no. 6, pp. 1574–1587, 2014. View at Publisher · View at Google Scholar
  34. S. A. Meenach, K. W. Anderson, J. Zach Hilt, R. C. McGarry, and H. M. Mansour, “Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer,” European Journal of Pharmaceutical Sciences, vol. 49, no. 4, pp. 699–711, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Ungaro, I. d'Angelo, C. Coletta et al., “Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers,” Journal of Controlled Release, vol. 157, no. 1, pp. 149–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Hu, Y. Dong, G. Pastorin, W. K. Ng, and R. B. H. Tan, “Spherical agglomerates of pure drug nanoparticles for improved pulmonary delivery in dry powder inhalers,” Journal of Nanoparticle Research, vol. 15, no. 4, article 1560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Nekkanti, N. Venkatesan, and G. V. Betageri, “Proliposomes for oral delivery: progress and challenges,” Current Pharmaceutical Biotechnology, vol. 16, no. 4, pp. 303–312, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Chu, S.-S. Tong, Y. Xu et al., “Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo,” Acta Pharmacologica Sinica, vol. 32, no. 7, pp. 973–980, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. Y.-Z. Li, X. Sun, T. Gong, J. Liu, J. Zuo, and Z.-R. Zhang, “Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles,” Pharmaceutical Research, vol. 27, no. 9, pp. 1977–1986, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Patil-Gadhe, A. Kyadarkunte, M. Patole, and V. Pokharkar, “Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 88, no. 1, pp. 169–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Patil-Gadhe and V. Pokharkar, “Pulmonary targeting potential of rosuvastatin loaded nanostructured lipid carrier: optimization by factorial design,” International Journal of Pharmaceutics, vol. 501, no. 1-2, pp. 199–210, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Dudala, P. Yalavarthi, H. Vadlamudi, J. Thanniru, G. Yaga, and N. Mudumala, “A perspective overview on lipospheres as lipid carrier systems,” International Journal of Pharmaceutical Investigation, vol. 4, no. 4, pp. 149–155, 2014. View at Publisher · View at Google Scholar
  43. S. Naikwade and A. Bajaj, “Preparation and in vitro evaluation of budesonide spray dried microparticles for pulmonary delivery,” Scientia Pharmaceutica, vol. 77, no. 2, pp. 419–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Adi, P. M. Young, H.-K. Chan, H. Agus, and D. Traini, “Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease,” European Journal of Pharmaceutical Sciences, vol. 40, no. 3, pp. 239–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Niwa, D. Mizutani, and K. Danjo, “Spray freeze-dried porous microparticles of a poorly water-soluble drug for respiratory delivery,” Chemical and Pharmaceutical Bulletin, vol. 60, no. 7, pp. 870–876, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. C. Fontana, T. L. Durli, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, “Polymeric controlled release inhalable powder produced by vibrational spray-drying: one-step preparation and in vitro lung deposition,” Powder Technology, vol. 258, pp. 49–59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Sansone, R. P. Aquino, P. D. Gaudio, P. Colombo, and P. Russo, “Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 1, pp. 206–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Kundawala, V. Patel, H. Patel, and D. Choudhary, “Treating tuberculosis with chitosan microparticles loaded with rifampicin as respirable powder for pulmonary delivery,” Indian Journal of Novel Drug Delivery, vol. 4, pp. 57–65, 2012. View at Google Scholar
  49. M. V. Vadakkan, S. S. Binil Raj, C. C. Kartha, and G. S. Vinod Kumar, “Cationic, amphiphilic dextran nanomicellar clusters as an excipient for dry powder inhaler formulation,” Acta Biomaterialia, vol. 23, pp. 172–188, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. M. A. Darbandi, N. A. Rouholamini, K. Gilani, and H. Tajerzadeh, “The effect of vehicles on spray drying of rifampicin inhalable microparticles: in vitro and in vivo evaluation,” DARU Journal of Pharmaceutical Sciences, vol. 16, no. 3, pp. 128–135, 2008. View at Google Scholar · View at Scopus
  51. J.-J. Yang, C.-Y. Liu, L.-H. Quan, and Y.-H. Liao, “Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers,” AAPS PharmSciTech, vol. 13, no. 3, pp. 816–825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. T. P. Learoyd, J. L. Burrows, E. French, and P. C. Seville, “Sustained delivery by leucine-modified chitosan spray-dried respirable powders,” International Journal of Pharmaceutics, vol. 372, no. 1-2, pp. 97–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Arora, M. Haghi, C.-Y. Loo, D. Traini, P. M. Young, and S. Jain, “Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection,” Molecular Pharmaceutics, vol. 12, no. 6, pp. 2001–2009, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Daman, K. Gilani, A. Rouholamini Najafabadi, H. R. Eftekhari, and M. A. Barghi, “Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique,” DARU, Journal of Pharmaceutical Sciences, vol. 22, no. 1, article 50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Scalia, M. Haghi, V. Losi, V. Trotta, P. M. Young, and D. Traini, “Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery,” European Journal of Pharmaceutical Sciences, vol. 49, no. 2, pp. 278–285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Mezzena, S. Scalia, P. M. Young, and D. Traini, “Solid lipid budesonide microparticles for controlled release inhalation therapy,” The AAPS Journal, vol. 11, no. 4, pp. 771–778, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Kuzmov and T. Minko, “Nanotechnology approaches for inhalation treatment of lung diseases,” Journal of Controlled Release, vol. 219, pp. 500–518, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. A. J. Mali, A. P. Pawar, and R. N. Purohit, “Development of budesonide loaded biopolymer based dry powder inhaler: optimization, in vitro deposition, and cytotoxicity study,” Journal of Pharmaceutics, vol. 2014, Article ID 795371, 12 pages, 2014. View at Publisher · View at Google Scholar
  59. L.-M. Xu, Q.-X. Zhang, Y. Zhou, H. Zhao, J.-X. Wang, and J.-F. Chen, “Engineering drug ultrafine particles of beclomethasone dipropionate for dry powder inhalation,” International Journal of Pharmaceutics, vol. 436, no. 1-2, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. R. S. Dhumal, S. V. Biradar, A. R. Paradkar, and P. York, “Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery,” International Journal of Pharmaceutics, vol. 368, no. 1-2, pp. 129–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. Q. Zhou, L. Qu, T. Gengenbach, I. Larson, P. J. Stewart, and D. A. V. Morton, “Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers,” AAPS PharmSciTech, vol. 14, no. 1, pp. 38–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. N. R. Rabbani and P. C. Seville, “The influence of formulation components on the aerosolisation properties of spray-dried powders,” Journal of Controlled Release, vol. 110, no. 1, pp. 130–140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. X. Wu, W. Zhang, D. Hayes Jr., and H. M. Mansour, “Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery,” International Journal of Nanomedicine, vol. 8, pp. 1269–1283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Singh, L. V. S. K. Koduri, A. Singh, and S. Suresh, “Novel potential for optimization of antitubercular therapy: pulmonary delivery of rifampicin lipospheres,” Asian Journal of Pharmaceutical Sciences, vol. 10, no. 6, pp. 549–562, 2015. View at Publisher · View at Google Scholar
  65. M. C. Gaspar, J. J. S. Sousa, A. A. C. C. Pais et al., “Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 96, pp. 65–75, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. H. S. Mahajan and S. A. Gundare, “Preparation, characterization and pulmonary pharmacokinetics of xyloglucan microspheres as dry powder inhalation,” Carbohydrate Polymers, vol. 102, no. 1, pp. 529–536, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Diab, J. Brillault, A. Bardy, A. V. L. Gontijo, and J. C. Olivier, “Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: efficiency for ex vivo alveolar macrophage targeting,” International Journal of Pharmaceutics, vol. 436, no. 1-2, pp. 833–839, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. R. A. Tuli, T. R. Dargaville, G. A. George, and N. Islam, “Polycaprolactone microspheres as carriers for dry powder inhalers: effect of surface coating on aerosolization of salbutamol sulfate,” Journal of Pharmaceutical Sciences, vol. 101, no. 2, pp. 733–745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. D. J. Singh, A. A. Lohade, J. J. Parmar et al., “Development of chitosan-based dry powder inhalation system of cisplatin for lung cancer,” Indian Journal of Pharmaceutical Sciences, vol. 74, no. 6, pp. 521–526, 2012. View at Publisher · View at Google Scholar
  70. A. Pawar, C. Bothiraja, K. Shaikh, and A. Mali, “An insight into cochleates, a potential drug delivery system,” RSC Advances, vol. 5, no. 99, pp. 81188–81202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. G. Pilcer, T. Sebti, and K. Amighi, “Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation,” Pharmaceutical Research, vol. 23, no. 5, pp. 931–940, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Endo, S. Amikawa, A. Matsumoto, N. Sahashi, and S. Onoue, “Erythritol-based dry powder of glucagon for pulmonary administration,” International Journal of Pharmaceutics, vol. 290, no. 1-2, pp. 63–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Onoue, K. Yamamoto, Y. Kawabata, M. Hirose, T. Mizumoto, and S. Yamada, “Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery,” International Journal of Pharmaceutics, vol. 382, no. 1-2, pp. 144–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. A. G. Balducci, S. Cagnani, F. Sonvico et al., “Pure insulin highly respirable powders for inhalation,” European Journal of Pharmaceutical Sciences, vol. 51, no. 1, pp. 110–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Depreter and K. Amighi, “Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 3, pp. 454–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. V. Saluja, J.-P. Amorij, J. C. Kapteyn, A. H. de Boer, H. W. Frijlink, and W. L. J. Hinrichs, “A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation,” Journal of Controlled Release, vol. 144, no. 2, pp. 127–133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. N. K. Kunda, I. M. Alfagih, E. N. Miyaji et al., “Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles,” International Journal of Pharmaceutics, vol. 495, no. 2, pp. 903–912, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Shur, T. G. Nevell, R. J. Ewen et al., “Cospray-dried unfractionated heparin with l-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy,” Journal of Pharmaceutical Sciences, vol. 97, no. 11, pp. 4857–4868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Jalalipour, K. Gilani, H. Tajerzadeh, A. R. Najafabadi, and M. Barghi, “Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents,” International Journal of Pharmaceutics, vol. 352, no. 1-2, pp. 209–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Lu, L. Garcia-Contreras, P. Muttil et al., “Pulmonary immunization using antigen 85-b polymeric microparticles to boost tuberculosis immunity,” The AAPS Journal, vol. 12, no. 3, pp. 338–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Wicki, D. Witzigmann, V. Balasubramanian, and J. Huwyler, “Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications,” Journal of Controlled Release, vol. 200, pp. 138–157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. Le Breton, and V. Préat, “PLGA-based nanoparticles: an overview of biomedical applications,” Journal of Controlled Release, vol. 161, no. 2, pp. 505–522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. D.-C. Li, X.-K. Zhong, Z.-P. Zeng et al., “Application of targeted drug delivery system in Chinese medicine,” Journal of Controlled Release, vol. 138, no. 2, pp. 103–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Zhang, L. Wu, H.-K. Chan, and W. Watanabe, “Formation, characterization, and fate of inhaled drug nanoparticles,” Advanced Drug Delivery Reviews, vol. 63, no. 6, pp. 441–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. N. Tsapis, D. Bennett, B. Jackson, D. A. Weitz, and D. A. Edwards, “Trojan particles: large porous carriers of nanoparticles for drug delivery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 19, pp. 12001–12005, 2002. View at Publisher · View at Google Scholar · View at Scopus
  86. W. S. Cheow, M. L. L. Ng, K. Kho, and K. Hadinoto, “Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants,” International Journal of Pharmaceutics, vol. 404, no. 1-2, pp. 289–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. G. Kaptay, “The gibbs equation versus the kelvin and the gibbs-thomson equations to describe nucleation and equilibrium of nano-materials,” Journal of Nanoscience and Nanotechnology, vol. 12, no. 3, pp. 2625–2633, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. B. E. Rabinow, “Nanosuspensions in drug delivery,” Nature Reviews Drug Discovery, vol. 3, no. 9, pp. 785–796, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. W. Yang, J. I. Peters, and R. O. Williams III, “Inhaled nanoparticles-a current review,” International Journal of Pharmaceutics, vol. 356, no. 1-2, pp. 239–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. J. C. Sung, D. J. Padilla, L. Garcia-Contreras et al., “Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery,” Pharmaceutical Research, vol. 26, no. 8, pp. 1847–1855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Wang, K. Kho, W. S. Cheow, and K. Hadinoto, “A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles,” International Journal of Pharmaceutics, vol. 424, no. 1-2, pp. 98–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. S. M. D'Addio, J. G. Y. Chan, P. C. L. Kwok, B. R. Benson, R. K. Prud'Homme, and H.-K. Chan, “Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying,” Pharmaceutical Research, vol. 30, no. 11, pp. 2891–2901, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. S. M. D'Addio, J. G. Y. Chan, P. C. L. Kwok, R. K. Prud'homme, and H.-K. Chan, “Constant size, variable density aerosol particles by ultrasonic spray freeze drying,” International Journal of Pharmaceutics, vol. 427, no. 2, pp. 185–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Pardeike, A. Hommoss, and R. H. Müller, “Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products,” International Journal of Pharmaceutics, vol. 366, no. 1-2, pp. 170–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Weber, A. Zimmer, and J. Pardeike, “Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 86, no. 1, pp. 7–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Pawar, S. Rajalakshmi, P. Mehta, K. Shaikh, and C. Bothiraja, “Strategies for formulation development of andrographolide,” RSC Advances, vol. 6, no. 73, pp. 69282–69300, 2016. View at Publisher · View at Google Scholar
  97. W. Mehnert and K. Mäder, “Solid lipid nanoparticles: production, characterization and applications,” Advanced Drug Delivery Reviews, vol. 47, no. 2-3, pp. 165–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. R. R. Patlolla, M. Chougule, A. R. Patel, T. Jackson, P. N. V. Tata, and M. Singh, “Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers,” Journal of Controlled Release, vol. 144, no. 2, pp. 233–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. A. J. Mali, A. P. Pawar, and C. Bothiraja, “Improved lung delivery of budesonide from biopolymer based dry powder inhaler through natural inhalation of rat,” Materials Technology, vol. 29, no. 6, pp. 350–357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. I. S. Chandiran, B. Pavan Kumar, and K. N. Jayaveera, “Design and development of microparticulate drug delivery system of Glimepiride for controlled release,” Drug Invention Today, vol. 5, no. 3, pp. 235–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. N. K. Varde and D. W. Pack, “Microspheres for controlled release drug delivery,” Expert Opinion on Biological Therapy, vol. 4, no. 1, pp. 35–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. M. F. Ali and S. Bakalis, “Mucoadhesive polymers for food formulations,” Procedia Food Science, vol. 1, pp. 68–75, 2011. View at Publisher · View at Google Scholar
  103. M. Mishra and B. Mishra, “Mucoadhesive microparticles as potential carriers in inhalation delivery of doxycycline hyclate: a comparative study,” Acta Pharmaceutica Sinica B, vol. 2, no. 5, pp. 518–526, 2012. View at Publisher · View at Google Scholar
  104. M. Sakagami, W. Kinoshita, K. Sakon, J. Sato, and Y. Makino, “Mucoadhesive beclomethasone microspheres for powder inhalation: Their pharmacokinetics and pharmacodynamics evaluation,” Journal of Controlled Release, vol. 80, no. 1-3, pp. 207–218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. R. Kamble, P. Palve, and P. Mehta, “Preparation and evaluation of amorphous olmesartan medoxomil with porous silica microparticles using spray-drying technique,” Journal of Advanced Pharmacy Education & Research, vol. 4, pp. 65–71, 2014. View at Google Scholar
  106. C. Bothiraja, M. B. Shinde, S. Rajalakshmi, and A. P. Pawar, “Evaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide-PVP,” Journal of Pharmacy and Pharmacology, vol. 61, no. 11, pp. 1465–1472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. V. Dhapte and P. Mehta, “Advances in hydrotropic solutions: an updated review,” St. Petersburg Polytechnical University Journal: Physics and Mathematics, vol. 1, no. 4, pp. 424–435, 2015. View at Publisher · View at Google Scholar
  108. C. Duret, N. Wauthoz, T. Sebti, F. Vanderbist, and K. Amighi, “Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties,” International Journal of Pharmaceutics, vol. 428, no. 1-2, pp. 103–113, 2012. View at Publisher · View at Google Scholar
  109. S. Onoue, H. Sato, Y. Kawabata, T. Mizumoto, N. Hashimoto, and S. Yamada, “In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy,” Journal of Controlled Release, vol. 138, no. 1, pp. 16–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. D.-J. Van Drooge, W. L. J. Hinrichs, B. H. J. Dickhoff et al., “Spray freeze drying to produce a stable Δ9-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation,” European Journal of Pharmaceutical Sciences, vol. 26, no. 2, pp. 231–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. N. A. Beinborn, J. Du, N. P. Wiederhold, H. D. C. Smyth, and R. O. Williams III, “Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 81, no. 3, pp. 600–608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. K. A. Overhoff, K. P. Johnston, J. Tam, J. Engstrom, and R. O. Williams III, “Use of thin film freezing to enable drug delivery: a review,” Journal of Drug Delivery Science and Technology, vol. 19, no. 2, pp. 89–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. Y.-B. Wang, A. B. Watts, J. I. Peters, S. Liu, A. Batra, and R. O. Williams III, “In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization,” AAPS PharmSciTech, vol. 15, no. 4, pp. 981–993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. F. Depreter, G. Pilcer, and K. Amighi, “Inhaled proteins: challenges and perspectives,” International Journal of Pharmaceutics, vol. 447, no. 1-2, pp. 251–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. T. Sou, E. N. Meeusen, M. de Veer, D. A. V. Morton, L. M. Kaminskas, and M. P. McIntosh, “New developments in dry powder pulmonary vaccine delivery,” Trends in Biotechnology, vol. 29, no. 4, pp. 191–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. J. Wee, J. Scheerlinck, K. Snibson et al., “Pulmonary delivery of iscomatrix influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing,” Mucosal Immunology, vol. 1, pp. 489–496, 2008. View at Google Scholar
  117. J. Huang, R. J. Garmise, T. M. Crowder et al., “A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats,” Vaccine, vol. 23, no. 6, pp. 794–801, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. M. Witting, K. Obst, W. Friess, and S. Hedtrich, “Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers,” Biotechnology Advances, vol. 33, no. 6, pp. 1355–1369, 2015. View at Publisher · View at Google Scholar · View at Scopus
  119. A. Alhalaweh, W. Kaialy, G. Buckton, H. Gill, A. Nokhodchi, and S. P. Velaga, “Theophylline cocrystals prepared by spray drying: physicochemical properties and aerosolization performance,” AAPS PharmSciTech, vol. 14, no. 1, pp. 265–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Arora, R. R. Mahajan, V. Kushwah, D. Baradia, A. Misra, and S. Jain, “Development of voriconazole loaded large porous particles for inhalation delivery: effect of surface forces on aerosolisation performance, assessment of in vitro safety potential and uptake by macrophages,” RSC Advances, vol. 5, no. 48, pp. 38030–38043, 2015. View at Publisher · View at Google Scholar · View at Scopus
  121. A.-Z. Chen, C. Zhao, S.-B. Wang, Y.-G. Liu, and D.-L. Lin, “Generation of porous poly-L-lactide microspheres by emulsion-combined precipitation with a compressed CO2 antisolvent process,” Journal of Materials Chemistry B, vol. 1, no. 23, pp. 2967–2975, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. T. Parumasivam, J. G. Chan, A. Pang et al., “In vitro evaluation of inhalable verapamil-rifapentine particles for tuberculosis therapy,” Molecular Pharmaceutics, vol. 13, no. 3, pp. 979–989, 2016. View at Publisher · View at Google Scholar